These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10392668)

  • 41. The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review.
    Weberschock T; Meister AC; Bohrt K; Schmitt J; Boehncke WH; Ludwig RJ
    Contact Dermatitis; 2011 Oct; 65(4):187-94. PubMed ID: 21631519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy.
    Schindewolf M; Gobst C; Kroll H; Recke A; Louwen F; Wolter M; Kaufmann R; Boehncke WH; Lindhoff-Last E; Ludwig RJ
    J Allergy Clin Immunol; 2013 Jul; 132(1):131-9. PubMed ID: 23726261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-Molecular-Weight Heparins as Immunomodulators in Dermatology Practice.
    Solak B
    Am J Ther; 2016; 23(6):e1911-e1917. PubMed ID: 25853237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
    Jappe U
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
    Jappe U; Juschka U; Kuner N; Hausen BM; Krohn K
    Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential diagnosis of late-type reactions to injected local anaesthetics: Inflammation at the injection site is the only indicator of allergic hypersensitivity.
    Trautmann A; Stoevesandt J
    Contact Dermatitis; 2019 Feb; 80(2):118-124. PubMed ID: 30311217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Necrotizing skin lesions induced by low-molecular-weight heparin after total knee arthroplasty.
    Plath J; Schulze R; Barz D; Krammer B; Steiner M; Anders O; Mach J
    Arch Orthop Trauma Surg; 1997; 116(6-7):443-5. PubMed ID: 9266063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heparin-induced skin lesions.
    Schindewolf M; Lindhoff-Last E; Ludwig RJ; Boehncke WH
    Lancet; 2012 Nov; 380(9856):1867-79. PubMed ID: 22642893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Heparins].
    Marbet GA
    Ther Umsch; 2003 Jan; 60(1):10-3. PubMed ID: 12638471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low molecular weight heparin (LMWH)-induced skin necrosis in a patient with unstable angina.
    Ang KL; Bose A; Halil O; Cummins D; Amrani M
    Int J Cardiol; 2003 Oct; 91(2-3):239-40. PubMed ID: 14559137
    [No Abstract]   [Full Text] [Related]  

  • 51. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
    Lopez S; Torres MJ; Rodríguez-Pena R; Blanca-Lopez N; Fernandez TD; Antunez C; Canto G; de Luque V; Mayorga C
    Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute generalized exanthematous pustulosis from dalteparin.
    Komericki P; Grims R; Kränke B; Aberer W
    J Am Acad Dermatol; 2007 Oct; 57(4):718-21. PubMed ID: 17610994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
    Casele HL
    Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticoagulant-related skin reactions.
    Jörg I; Fenyvesi T; Harenberg J
    Expert Opin Drug Saf; 2002 Sep; 1(3):287-94. PubMed ID: 12904144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-molecular-weight subcutaneous heparin-induced skin necrosis.
    Montserrat I; Lopez D; Zuazu-Jausoro I; Perez M; de Moragas JM; Fontcuberta J
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):751-2. PubMed ID: 1966800
    [No Abstract]   [Full Text] [Related]  

  • 57. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection.
    Trautmann A; Seitz CS
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):469-80. PubMed ID: 19563992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delayed-type hypersensitivity to subcutaneous enoxaparin.
    Méndez J; Sanchís ME; de la Fuente R; Stolle R; Vega JM; Martínez C; Armentia A; Sánchez P; Fernández A
    Allergy; 1998 Oct; 53(10):999-1003. PubMed ID: 9821483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
    ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
    Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies.
    Tonn ME; Schaiff RA; Kollef MH
    Ann Pharmacother; 1997 Mar; 31(3):323-6. PubMed ID: 9066940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.